MDS Virtual Congress 2020 Archives - Page 112 of 149

Progression of cortical thinning in Parkinson’s disease

A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montréal, QC, Canada)
Progressive supra nuclear palsy phenotype with idiopathic basal ganglia calcification

R. Ramesh, V. Paramanandham, S. Venkatasubramanian, S. Shanmugam (Chennai, India)
Progressive supranuclear palsy: Common metabolic pattern in different variants

G. Martí-Andrés, L. Van Bommel, S. Meles, M. Riverol, R. Valentí, R.V Kogan, R.J Renken, V. Gurvits, T. Van Laar, M. Pagani, E. Prieto, M.R Luquin, K.L Leenders, J. Arbizu (Pamplona, Spain)
Prospective assessment of the lessebo effect in placebo-controlled randomized trials using an expectancy questionnaire

T. Mestre, E. Macklin, C. Coffey, M. Kostrzebski, A. Ascherio, J. Ferreira, M. Schwarzschild, T. Simuni, A. Lang (Ottawa, ON, Canada)
Prospective investigation of the frequency of tardive syndromes in outpatients attending two specialist psychiatry hospitals in Lagos, Nigeria

E. Campbell, B. Fadipe, O. Ojo, S. Oluwaniyi, N. Okubadejo (Surulere, Nigeria)
Protective role of astrocytes on α-synuclein accumulation and propagation

T. Tsunemi, Y. Ishiguro, A. Yoroisaka, K. Krainc, N. Hattori (Tokyo, Japan)
Psychiatric comorbidities in Young Onset Parkinson’s disease

A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)
Psychometric properties of clinical indicators of device-aided therapy eligibility among Parkinson’s disease patients: Real-world data from 6 countries

K. Chaudhuri, R. Pahwa, S. Isaacson, A. Merola, A. Alobaidi, P. Kandukuri, J.C Parra, L. Bergmann, E. Jones, A. Antonini (London, United Kingdom)
Psychosocial Adjustment to Illness Scale in family carers of patients with Parkinson’s disease: Spanish validation

L. Ambrosio, M.C Portillo, R. Martin-Lanas, M.V Navarta-Sanchez, M. Riverol (Pamplona, Spain)
Pulmonary function in Parkinson’s disease

A. O'Callaghan, W. Gray, S. Bourke, R. Walker (North Shields, United Kingdom)